These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5745527)

  • 21. Combined administration of barbourin--albumin and hirudin--albumin fusion proteins limits fibrin(ogen) deposition on the rabbit balloon-injured aorta.
    Sheffield WP; Gataiance S; Eltringham-Smith LJ
    Thromb Res; 2007; 119(2):195-207. PubMed ID: 16478628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levels of fibrinolytic activators and inhibitors in plasma after severe trauma.
    Sørensen JV
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):43-9. PubMed ID: 7514044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term experience of girdling the ascending aorta with Dacron mesh as definitive treatment for aneurysmal dilation.
    Cohen O; Odim J; De la Zerda D; Ukatu C; Vyas R; Vyas N; Palatnik K; Laks H
    Ann Thorac Surg; 2007 Feb; 83(2):S780-4; discussion S785-90. PubMed ID: 17257926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The antithrombophilic complex of the arterial wall in the therapy of obliterating arteriopathies in lower limbs (author's transl)].
    Catalano M; Carzaniga G; Fiore G; Lunardi L; Libretti A
    G Ital Cardiol; 1980; 10(11):1491-5. PubMed ID: 7202897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential inhibition with antifibrinolytic agents of staphylokinase and streptokinase induced clot lysis.
    Lijnen HR; Stassen JM; Collen D
    Thromb Haemost; 1995 May; 73(5):845-9. PubMed ID: 7482414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fibrinolytic therapy of phlegmasia coerulea dolens].
    Kéki K; Szabados R; Nemes T; Tarján L
    Orv Hetil; 1981 Jun; 122(23):1377-9. PubMed ID: 7279409
    [No Abstract]   [Full Text] [Related]  

  • 27. Determinants of bleeding risk in patients on antithrombotic and antifibrinolytic drugs.
    Meijer K; Schulman S
    Semin Thromb Hemost; 2008 Nov; 34(8):762-71. PubMed ID: 19214914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 29. [The use of thrombolytin in the treatment o thromboses of peripheral vessels].
    Bogomolova LG; Grsbenshchikova LA; Izmaĭlova EF; Kotovshchikova MA
    Vestn Khir Im I I Grek; 1966 Jun; 96(6):3-6. PubMed ID: 6000581
    [No Abstract]   [Full Text] [Related]  

  • 30. Mobile thrombus of the thoracic aorta: management and treatment review.
    Piffaretti G; Tozzi M; Mariscalco G; Bacuzzi A; Lomazzi C; Rivolta N; Carrafiello G; Castelli P
    Vasc Endovascular Surg; 2008; 42(5):405-11. PubMed ID: 19000981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta.
    Asada Y; Hara S; Tsuneyoshi A; Hatakeyama K; Kisanuki A; Marutsuka K; Sato Y; Kamikubo Y; Sumiyoshi A
    Thromb Haemost; 1998 Sep; 80(3):506-11. PubMed ID: 9759635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro studies of staphylokinase.
    Sweet B; McNicol GP; Douglas AS
    Clin Sci; 1965 Oct; 29(2):375-82. PubMed ID: 5840981
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical experience with fibrin membrane for burns].
    Kobayashi M
    Shujutsu; 1966 Nov; 20(11):1003-5. PubMed ID: 5979037
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study on guidelines for the treatment of DIC].
    Wada H
    Rinsho Ketsueki; 2007 May; 48(5):377-85. PubMed ID: 17571582
    [No Abstract]   [Full Text] [Related]  

  • 35. [Quantitative estimation of components in the media of aortic wall using Imagelyzer system].
    Masuda K; Iwa N; Katayama Y; Yutani C; Ito K; Go S
    Rinsho Byori; 1984 Sep; 32(9):1017-20. PubMed ID: 6520985
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the mast cell content of the arterial wall in arteriosclerosis].
    Puchlev A; Jurukowa Z; Kiprov D
    Z Gesamte Inn Med; 1966 Nov; 21(21):Suppl:277-9. PubMed ID: 5994735
    [No Abstract]   [Full Text] [Related]  

  • 37. Septal reconstruction in nasal septum surgery with a composite-sandwich technique.
    Savoca A; Brandimarte F; Molina S; Perazzitti L
    Rhinology; 1997 Mar; 35(1):37-8. PubMed ID: 9200262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional activities and concentrations of plasmin inhibitors in normal subjects and D.I.C. patients.
    Velasco F; Torres A; Andres P; Duran MI
    Thromb Haemost; 1982 Jun; 47(3):275-7. PubMed ID: 6180498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: report of the Cooperative Aneurysm Study.
    Torner JC; Kassell NF; Wallace RB; Adams HP
    Neurosurgery; 1981 Nov; 9(5):506-13. PubMed ID: 7322311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Coagulo-fibrinolytic system and platelets in cancer--clinical and experimental study on the influence of coagulo-fibrinolytic system and platelets on tumor growth and metastasis].
    Ojiro M
    Igaku Kenkyu; 1983 Mar; 53(2):63-99. PubMed ID: 6375232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.